Related Experiment Video
Updated: Aug 7, 2026

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis
Published on: April 5, 2017
Interaction of rifabutin with model membranes
Yu N Shakina1, V V Vostrikov, G M Sorokoumova
1M. V. Lomonosov Moscow State Academy of Fine Chemical Technology.
This study shows that rifabutin (a tuberculosis drug) binds to liposomes through electrostatic and hydrophobic interactions, influenced by phospholipid composition and ionic strength. This binding affects the drug's activity.
Area of Science:
- Pharmacology
- Drug Delivery
- Biochemistry
Background:
- Rifabutin is a key antibiotic for treating tuberculosis.
- Liposomes are widely investigated as drug delivery systems.
- Understanding drug-liposome interactions is crucial for optimizing drug efficacy.
Purpose of the Study:
- To investigate the binding characteristics of rifabutin to liposomes.
- To determine the influence of liposome composition on rifabutin binding.
- To elucidate the nature of rifabutin-liposome interactions.
Main Methods:
- Gel filtration chromatography for separating liposomal and free rifabutin.
- Quantification of rifabutin bound to liposomes with varying phospholipid compositions.
- Fluorescence quenching assays to study drug-lipid interactions.
Main Results:
- Negatively charged phospholipids significantly enhanced rifabutin binding.
- Increased ionic strength reduced rifabutin binding to liposomes.
- Fluorescence quenching indicated interactions between rifabutin and anthryl phosphatidylcholine-containing liposomes.
- Liposome phospholipid composition influenced rifabutin's activity.
Conclusions:
- Rifabutin binding to liposomes is mediated by both electrostatic and hydrophobic forces.
- Liposome formulation can modulate rifabutin's interaction and potentially its therapeutic effect.
- These findings provide insights for developing liposomal rifabutin formulations.
More Related Videos
10:29A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis
Published on: March 24, 2017
10:29Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
Related Concept Videos
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
A recent model describes pravastatin's hepatobiliary excretion, mediated...
Methods for Studying Drug Absorption: In vitro
The diffusion cell method uses a two-compartment cell, including a donor compartment with the drug solution, which simulates the environment where the drug is applied, and a receptor compartment with a buffer solution, which simulates the environment...